Keyphrases
Risk Factors
100%
Cataract
100%
Aldose Reductase
100%
Diabetic
27%
Retinopathy
27%
Cell Growth
18%
Cell Apoptosis
18%
Non-diabetic
18%
ERK2
18%
Structural Change
18%
Diabetes Induction
18%
Metabolic Control
18%
JNK1
18%
Experimental Diabetes
18%
Diabetic Eye Disease
18%
High Risk
9%
Hyperglycemia
9%
Overexpression
9%
Gene Expression
9%
Diabetes
9%
Non-transgenic
9%
Transgenic Mice
9%
Lens Transparency
9%
Vacuole
9%
Homeostasis
9%
C-Jun
9%
Extracellular Signal-regulated Kinase
9%
Severe Complications
9%
Patients with Diabetes
9%
WT Control
9%
Early Signs
9%
ERK Pathway
9%
Insulin Deficiency
9%
Heterozygote
9%
JNK Pathway
9%
Sorbitol
9%
Ocular Complications
9%
Aldo-keto Reductase Family 1 Member B1 (AKR1B1)
9%
Lenticular
9%
Medicine and Dentistry
Cataract
100%
Aldehyde Reductase
100%
Diabetes Mellitus
36%
Retinopathy
27%
Cell Growth
18%
Diabetes
18%
Transgene
18%
Programmed Cell Death
18%
Mitogen Activated Protein Kinase 3
18%
Eye Disease
18%
Metabolic Regulation
18%
Diabetogenesis
18%
Experimental Diabetes Mellitus
18%
Homeostasis
9%
Hyperglycemia
9%
Transgenic Mouse
9%
Amino Terminal Sequence
9%
Gene Expression
9%
Mitogen-Activated Protein Kinase
9%
Vacuolization
9%
Sorbitol
9%
Insulin Deficiency
9%
Neuroscience
Cataract
100%
Aldehyde Reductase
100%
Diabetes Mellitus
36%
Retinal Disease
27%
Cell Growth
18%
Transgene
18%
Ophthalmic Disorder
18%
Mitogen Activated Protein Kinase 3
18%
Programmed Cell Death
18%
Gene Expression
9%
Hyperglycemia
9%
Amino Terminal Sequence
9%
Extracellular Signal-Regulated Kinases
9%
Sorbitol
9%
Biochemistry, Genetics and Molecular Biology
Aldose Reductase
100%
Transgene
18%
Cell Growth
18%
Metabolic Regulation
18%
Programmed Cell Death
18%
Hyperglycemia
9%
Gene Expression
9%
Transgenic Mouse
9%
Homeostasis
9%
N-Terminus
9%
Extracellular Signal-Regulated Kinases
9%
Sorbitol
9%